NASDAQ : FENC
Fennec Pharmaceuticals Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 359.09M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Fennec Pharmaceuticals Inc. (FENC) reported revenue of 59.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 59.22M | 44.64M | 47.54M | 21.25M | 1.53M | |
| Cost of Revenue | 3.71M | 3.76M | 3.18M | 1.26M | 86.00K | |
| Gross Profit | 55.51M | 40.88M | 44.35M | 19.99M | 1.45M | |
| Selling, General & Admin | 56.41M | 46.91M | 41.48M | 32.71M | 20.51M | 12.24M |
| Research & Development | 216.00K | 250.00K | 307.00K | 56.00K | 3.53M | 4.98M |
| Operating Expenses | 56.63M | 47.16M | 41.79M | 32.76M | 24.04M | 17.22M |
| Operating Income | -1.12M | -6.28M | 2.57M | -12.77M | -22.59M | -17.22M |
| Interest Expense | -942.00K | -2.14M | -4.16M | -3.68M | -1.13M | -142.00K |
| Interest & Investment Income | 1.01M | 787.00K | 1.68M | 441.00K | 195.00K | 54.00K |
| Currency Exchange Gain (Loss) | -20.00K | 28.00K | -82.00K | 5.00K | -9.00K | -10.00K |
| EBT Excluding Unusual Items | -1.08M | -7.61M | 10.00K | -16.01M | -23.53M | -17.32M |
| Gain (Loss) on Sale of Investments | -2.00K | -81.00K | -39.00K | -184.00K | -25.00K | |
| Other Unusual Items | -2.02M | -2.02M | ||||
| Pretax Income | -3.10M | -9.63M | -71.00K | -16.05M | -23.71M | -17.35M |
| Income Tax Expense | 148.00K | 106.00K | 365.00K | |||
| Net Income | -3.25M | -9.74M | -436.00K | -16.05M | -23.71M | -17.35M |
| Net Income to Common | -3.25M | -9.74M | -436.00K | -16.05M | -23.71M | -17.35M |
| Shares Outstanding (Basic) | 32.06M | 28.58M | 27.29M | 26.57M | 26.27M | 26.01M |
| Shares Outstanding (Diluted) | 32.06M | 28.58M | 27.29M | 26.57M | 26.27M | 26.01M |
| EPS (Basic) | -0.10 | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| EPS (Diluted) | -0.10 | -0.34 | -0.02 | -0.60 | -0.90 | -0.67 |
| Gross Margin | 93.73% | 91.57% | 93.30% | 94.08% | 94.40% | |
| Operating Margin | -1.90% | -14.07% | 5.40% | -60.09% | -1,471.60% | |
| Profit Margin | -5.49% | -21.82% | -0.92% | -75.50% | -1,544.89% | |
| EBITDA | -1.02M | -6.18M | 3.60M | |||
| EBITDA Margin | -1.73% | -13.84% | 7.57% | |||
| D&A For EBITDA | 102.67K | 102.67K | 1.03M | |||
| EBIT | -1.12M | -6.28M | 2.57M | -12.77M | -22.59M | -17.22M |
| EBIT Margin | -1.90% | -14.07% | 5.40% | -60.09% | ||
| Revenue as Reported | 59.22M | 44.64M | 47.54M | 21.25M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.25M | 36.79M | 26.63M | 13.27M | 23.77M | 21.10M |
| Cash & Short-Term Investments | 41.25M | 36.79M | 26.63M | 13.27M | 23.77M | 21.10M |
| Receivables | 23.27M | 23.22M | 12.88M | 8.81M | 1.54M | |
| Inventory | 2.37M | 1.56M | 1.06M | 2.16M | 576.00K | |
| Prepaid Expenses | 3.63M | 3.74M | 3.08M | 2.58M | 770.00K | 1.03M |
| Other Current Assets | 1.98M | 1.73M | 466.00K | 44.00K | 63.00K | 253.00K |
| Total Current Assets | 72.50M | 67.04M | 44.12M | 26.86M | 26.73M | 22.39M |
| Long-Term Accounts Receivable | 2.59M | 2.79M | ||||
| Long-Term Deferred Charges | 666.00K | 717.00K | 822.00K | 6.00K | 211.00K | 27.00K |
| Total Assets | 75.75M | 70.55M | 44.95M | 26.86M | 26.94M | 22.41M |
| Accounts Payable | 5.52M | 4.63M | 3.24M | 3.78M | 2.39M | 777.00K |
| Accrued Expenses | 3.70M | 5.63M | 3.43M | 3.75M | 2.22M | 877.00K |
| Current Portion of Leases | 2.00K | 21.00K | ||||
| Current Unearned Revenue | 3.18M | 248.00K | 248.00K | |||
| Total Current Liabilities | 12.39M | 10.52M | 6.92M | 7.55M | 4.61M | 1.65M |
| Long-Term Debt | 19.34M | 30.93M | 24.90M | 4.99M | ||
| Long-Term Unearned Revenue | 20.92M | 24.56M | 24.56M | 2.00K | ||
| Total Liabilities | 33.31M | 35.08M | 50.82M | 38.49M | 29.51M | 6.64M |
| Common Stock | 193.19M | 189.91M | 145.61M | 144.31M | 142.59M | 140.80M |
| Additional Paid-In Capital | 75.26M | 73.75M | 66.96M | 62.07M | 56.80M | 53.21M |
| Retained Earnings | -227.25M | -229.42M | -219.68M | -219.25M | -203.20M | -179.49M |
| Comprehensive Income & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Shareholders' Equity | 42.44M | 35.47M | -5.87M | -11.62M | -2.57M | 15.77M |
| Total Liabilities & Equity | 75.75M | 70.55M | 44.95M | 26.86M | 26.94M | 22.41M |
| Total Debt | 19.34M | 30.95M | 24.90M | 4.99M | ||
| Net Cash (Debt) | 41.25M | 36.79M | 7.29M | -17.68M | -1.12M | 16.11M |
| Net Cash Per Share | 1.29 | 1.29 | 0.27 | -0.67 | -0.04 | 0.62 |
| Filing Date Shares Outstanding | 35.07M | 34.48M | 27.59M | 27.10M | 26.41M | 26.01M |
| Total Common Shares Outstanding | 35.03M | 34.16M | 27.53M | 27.03M | 26.36M | 26.01M |
| Working Capital | 60.11M | 56.52M | 37.20M | 19.30M | 22.12M | 20.73M |
| Book Value Per Share | 1.21 | 1.04 | -0.21 | -0.43 | -0.10 | 0.61 |
| Tangible Book Value | 42.44M | 35.47M | -5.87M | -11.62M | -2.57M | 15.77M |
| Tangible Book Value Per Share | 1.21 | 1.04 | -0.21 | -0.43 | -0.10 | 0.61 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -3.25M | -9.74M | -436.00K | -16.05M | -23.71M | -17.35M |
| Other Amortization | 39.00K | 65.00K | 159.00K | 287.00K | 149.00K | 16.00K |
| Loss (Gain) From Sale of Investments | 2.00K | 81.00K | 39.00K | 184.00K | 25.00K | |
| Stock-Based Compensation | 7.50M | 7.03M | 5.06M | 5.35M | 4.22M | 4.01M |
| Provision & Write-off of Bad Debts | 644.00K | 2.21M | 4.60M | |||
| Other Operating Activities | 2.79M | 2.79M | 569.00K | |||
| Change in Accounts Receivable | -6.60M | -12.44M | -7.87M | -7.27M | -1.54M | |
| Change in Inventory | -946.00K | -1.28M | 579.00K | -1.58M | -576.00K | |
| Change in Accounts Payable | -425.00K | 1.39M | -537.00K | 1.39M | 1.61M | -794.00K |
| Change in Unearned Revenue | -710.00K | 24.81M | ||||
| Change in Other Net Operating Assets | -1.09M | -2.51M | -35.00K | 683.00K | 1.61M | -138.00K |
| Operating Cash Flow | -2.04M | -12.47M | 26.98M | -17.14M | -18.06M | -14.22M |
| Long-Term Debt Issued | 5.00M | 25.17M | 5.00M | |||
| Long-Term Debt Repaid | -19.48M | -13.00M | -5.00M | -14.00K | ||
| Net Debt Issued (Repaid) | -19.48M | -19.48M | -13.00M | 5.00M | 20.17M | 4.99M |
| Issuance of Common Stock | 47.34M | 44.24M | 1.30M | 1.72M | 928.00K | 33.00K |
| Repurchase of Common Stock | -1.33M | -187.00K | -176.00K | -78.00K | -194.00K | |
| Other Financing Activities | -1.95M | -1.95M | -1.74M | -175.00K | -41.00K | |
| Financing Cash Flow | 24.58M | 22.63M | -13.62M | 6.64M | 20.73M | 4.98M |
| Net Cash Flow | 22.54M | 10.15M | 13.37M | -10.51M | 2.67M | -9.24M |
| Levered Free Cash Flow | 1.07M | -7.33M | -289.75K | -12.35M | -9.17M | -7.73M |
| Unlevered Free Cash Flow | 1.62M | -6.06M | 2.15M | -10.34M | -8.61M | -7.66M |
| Cash Interest Paid | 4.16M | 4.16M | 3.82M | |||
| Cash Income Tax Paid | 748.00K | 748.00K | ||||
| Change in Working Capital | -9.77M | -14.83M | 16.94M | -6.78M | 1.10M | -932.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 369.61M | 262.98M | 173.61M | 302.87M | 252.10M | 114.43M |
| Enterprise Value | 328.36M | 260.41M | 165.39M | 316.14M | 247.04M | 95.08M |
| Last Close Price | 10.24 | 7.70 | 6.32 | 11.22 | 9.60 | 4.40 |
| Forward PE | 18.80 | 15.88 | 37.36 | 90.85 | 6.32 | 6.32 |
| PS Ratio | 6.17 | 5.89 | 3.65 | 14.25 | 164.24 | |
| PB Ratio | 8.45 | 7.41 | -29.57 | -26.06 | -98.13 | 7.25 |
| P/TBV Ratio | 8.61 | 7.41 | 7.25 | |||
| P/OCF Ratio | 6.43 | |||||
| EV/Sales Ratio | 5.48 | 5.83 | 3.48 | 14.88 | 160.94 | |
| EV/EBITDA Ratio | 45.94 | |||||
| EV/EBIT Ratio | 64.41 | |||||
| Debt / Equity Ratio | -3.29 | -2.66 | -9.69 | 0.32 | ||
| Debt / EBITDA Ratio | 5.37 | |||||
| Net Debt / Equity Ratio | -0.97 | -1.04 | 1.24 | -1.52 | -0.44 | -1.02 |
| Net Debt / EBITDA Ratio | 40.39 | 5.95 | -2.03 | |||
| Asset Turnover | 0.98 | 0.77 | 1.32 | 0.79 | 0.06 | |
| Inventory Turnover | 1.62 | 2.87 | 1.98 | 0.92 | ||
| Quick Ratio | 5.21 | 5.71 | 5.71 | 2.92 | 5.49 | 12.76 |
| Current Ratio | 5.85 | 6.37 | 6.38 | 3.56 | 5.80 | 13.54 |
| Return on Equity (ROE) | -18.58% | -65.82% | -359.22% | -77.36% | ||
| Return on Assets (ROA) | -1.17% | -6.80% | 4.47% | -29.67% | -57.21% | -39.99% |
| Return on Capital Employed (ROCE) | -1.80% | -10.50% | 6.80% | -66.10% | -101.20% | -83.00% |
| Earnings Yield | -0.96% | -3.70% | -0.25% | -5.30% | -9.41% | -15.16% |
| Buyback Yield / Dilution | -16.68% | -4.70% | -2.71% | -1.14% | -1.03% | -9.71% |